Difference between revisions of "WSI23-34-Case-5"

From MGH Learn Pathology
Line 23: Line 23:
 
|type=image
 
|type=image
 
|subject=Z0FBQUFBQmtKYTY3NzdoUHI2Y2hxQWM0RXhpanhHVktrM28tc0RuMFlSTXZKVHlzS3h2QTJUVjUwZjhSQVFfdm13aFBNSDZfcEt4OWxUY1oycjdQYzZyZkZXTFBZdjNBVUw4ODBwN3ZiVHZ3TnctS1BRTDYzZlE9
 
|subject=Z0FBQUFBQmtKYTY3NzdoUHI2Y2hxQWM0RXhpanhHVktrM28tc0RuMFlSTXZKVHlzS3h2QTJUVjUwZjhSQVFfdm13aFBNSDZfcEt4OWxUY1oycjdQYzZyZkZXTFBZdjNBVUw4ODBwN3ZiVHZ3TnctS1BRTDYzZlE9
 +
|identifier=WSI22-37-Case-6_1
 
|reasonCode=H&E
 
|reasonCode=H&E
 
|view=show
 
|view=show
Line 33: Line 34:
 
|type=image
 
|type=image
 
|subject=Z0FBQUFBQmtKYTdDSXptalJiQVhtaGd6T055VTlMa2Y2YXdmVl9mV01aNnpscXdIU3p2NkFuZXJkdFpWMU9GSGdmalN4TVJTelV0NnYxN2JsQTJtQ3VuUTdDbjBiZ0VHR3JfRTFab1RDVUNzSXN2amR1VVBKUXc9
 
|subject=Z0FBQUFBQmtKYTdDSXptalJiQVhtaGd6T055VTlMa2Y2YXdmVl9mV01aNnpscXdIU3p2NkFuZXJkdFpWMU9GSGdmalN4TVJTelV0NnYxN2JsQTJtQ3VuUTdDbjBiZ0VHR3JfRTFab1RDVUNzSXN2amR1VVBKUXc9
 +
|identifier=WSI22-37-Case-6_2
 
|reasonCode=H&E
 
|reasonCode=H&E
 
|view=show
 
|view=show
Line 43: Line 45:
 
|type=image
 
|type=image
 
|subject=Z0FBQUFBQmtKYTdSdXJ0VldZdjBDc0d5c2luZTNUS01WRmYtSU5HeE1HeDgtdW1rSUs5Y1VwSzVhNk94SVB2WlVqaVQwNlVjdUxjRDQyT2RvajNHdkJOb1Q2S19pUkxYR2x2a1hrNkdQMWs2eElYRUVfQ3hVMnc9
 
|subject=Z0FBQUFBQmtKYTdSdXJ0VldZdjBDc0d5c2luZTNUS01WRmYtSU5HeE1HeDgtdW1rSUs5Y1VwSzVhNk94SVB2WlVqaVQwNlVjdUxjRDQyT2RvajNHdkJOb1Q2S19pUkxYR2x2a1hrNkdQMWs2eElYRUVfQ3hVMnc9
 +
|identifier=WSI22-37-Case-6_3
 
|reasonCode=Trichrome
 
|reasonCode=Trichrome
 
|view=hide
 
|view=hide
Line 53: Line 56:
 
|type=image
 
|type=image
 
|subject=Z0FBQUFBQmtKYTdnU3pQOTUwX1JJMXVhdkRtbWNMcWdnX0dsNUZiU3h5em8xcFc1dTZzMnVfWlRrM1JzNnlSUExUVGozT3NzM2xKZm1yaUc1eDF5U0tzLXMzRFNhNkJYLUZWdWtpMFNfbXRTeUFpZndSaXlVQW89
 
|subject=Z0FBQUFBQmtKYTdnU3pQOTUwX1JJMXVhdkRtbWNMcWdnX0dsNUZiU3h5em8xcFc1dTZzMnVfWlRrM1JzNnlSUExUVGozT3NzM2xKZm1yaUc1eDF5U0tzLXMzRFNhNkJYLUZWdWtpMFNfbXRTeUFpZndSaXlVQW89
 +
|identifier=WSI22-37-Case-6_4
 
|reasonCode=Congo-red
 
|reasonCode=Congo-red
 
|view=hide
 
|view=hide
Line 63: Line 67:
 
|type=image
 
|type=image
 
|subject=Z0FBQUFBQmtKYTdxU0VFTDRBd3FWb0NjbGZwZ29GOWUwdlIyTnJkSjZybDY1eGtUR1FiRURYOXlGbkhxS1E4RjVpNHRPWC1sNFVBcTFWTFVISjV0OUxtRF83T3B2RXFha3o5T3BzX2xHOFU3RTBweElqTUFaQms9
 
|subject=Z0FBQUFBQmtKYTdxU0VFTDRBd3FWb0NjbGZwZ29GOWUwdlIyTnJkSjZybDY1eGtUR1FiRURYOXlGbkhxS1E4RjVpNHRPWC1sNFVBcTFWTFVISjV0OUxtRF83T3B2RXFha3o5T3BzX2xHOFU3RTBweElqTUFaQms9
 +
|identifier=WSI22-37-Case-6_5
 
|reasonCode=IgG
 
|reasonCode=IgG
 
|view=hide
 
|view=hide
Line 73: Line 78:
 
|type=image
 
|type=image
 
|subject=Z0FBQUFBQmtKYTcwN2paUHFNdUo3Wm03R3FDUHduRDVoTFlkYmk5WGpFQVFJZllqMFE0cGZiVDVNTDRyM09hNUxfUHFhMFktSlF6d1VoTzc2cTlJWENWQ0o2NE5ucUZ4YVpWWk9teXhXRFFtS3c2RmhGTFh0dnc9
 
|subject=Z0FBQUFBQmtKYTcwN2paUHFNdUo3Wm03R3FDUHduRDVoTFlkYmk5WGpFQVFJZllqMFE0cGZiVDVNTDRyM09hNUxfUHFhMFktSlF6d1VoTzc2cTlJWENWQ0o2NE5ucUZ4YVpWWk9teXhXRFFtS3c2RmhGTFh0dnc9
 +
|identifier=WSI22-37-Case-6_6
 
|reasonCode=IgG4
 
|reasonCode=IgG4
 
|view=hide
 
|view=hide
Line 83: Line 89:
 
|type=image
 
|type=image
 
|subject=Z0FBQUFBQmtKYTctTUd6VVFJajhfVUxJdHJ3YUZBLTI0cmJZWTdQN3N0b1d4VlU0RmJDUzJjQ3JxQW94c0tsQzliMlVSZUdScDNZUl9EWVRuOEw1cEtaS1UzWkp4WV9YcDVuQ0hxZE1FendodG03VHF6VWZLOUk9
 
|subject=Z0FBQUFBQmtKYTctTUd6VVFJajhfVUxJdHJ3YUZBLTI0cmJZWTdQN3N0b1d4VlU0RmJDUzJjQ3JxQW94c0tsQzliMlVSZUdScDNZUl9EWVRuOEw1cEtaS1UzWkp4WV9YcDVuQ0hxZE1FendodG03VHF6VWZLOUk9
 +
|identifier=WSI22-37-Case-6_7
 
|reasonCode=Smooth muscle actin (SMA)
 
|reasonCode=Smooth muscle actin (SMA)
 
|view=hide
 
|view=hide
Line 93: Line 100:
 
|type=image
 
|type=image
 
|subject=Z0FBQUFBQmtKYThSOEJuSlJUc0l1ajZMTG05ZHI4ZE5YY2E4cWdKeGJpRFc0R01WY3ZDTkt2MTIxQ2M3T2wzMFpkUFUxdkJpeVVnaXVUQ01CSzRCMl9peVFqWGtVbEJiM1RKSkotbktodjRBV2R3YWxYNUdLZEk9
 
|subject=Z0FBQUFBQmtKYThSOEJuSlJUc0l1ajZMTG05ZHI4ZE5YY2E4cWdKeGJpRFc0R01WY3ZDTkt2MTIxQ2M3T2wzMFpkUFUxdkJpeVVnaXVUQ01CSzRCMl9peVFqWGtVbEJiM1RKSkotbktodjRBV2R3YWxYNUdLZEk9
 +
|identifier=WSI22-37-Case-6_8
 
|reasonCode=ALK-tr
 
|reasonCode=ALK-tr
 
|view=hide
 
|view=hide
 
|modality=mrxs
 
|modality=mrxs
 
}}
 
}}

Revision as of 07:59, April 7, 2023

WSI23-34-Case-5
A 22-year-old woman with a 2.7 cm mass in RUL
Inflammatory myofibroblastic tumor
April 14, 2023 3:45:00 PM